Research News and Research

RSS

Researchers commence Phase 2 research study to test CERE-110 for AD

Researchers at Banner Sun Health Research Institute are about to start the first Phase 2 research study to test a gene transfer agent for Alzheimer's disease. AD is a degenerative and ultimately fatal disorder affecting as many as five million Americans and that number is expected to soar to more than 11 million by 2040.

7 Apr 2010

Study provides benchmark data to evaluate quality of management of sickle cell disease

The largest study to date of the use of acute care medical services by people with sickle cell disease found four of every 10 had to return to the hospital within 30 days of a previous hospitalization or go to the emergency department for treatment of pain, according to a new study funded in part by HHS' Agency for Healthcare Research and Quality.

7 Apr 2010

Tigermed Consulting signs alliance agreement with ICON

ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries and Tigermed Consulting, a leader in the provision of clinical drug development services in China, today announced that they have signed an alliance agreement.

7 Apr 2010

Research highlights first steps in the formation of Lewy bodies, the hallmark of Parkinson's brain

Although the cause of Parkinson's disease remains a mystery, scientists now have a better understanding of the earliest stages of abnormal aggregation of a key disease-associated protein. The research, published by Cell Press online on April 6th in Biophysical Journal, provides new insight into the first steps in the formation of neurotoxic structures called Lewy bodies that are the hallmark of the Parkinson's brain.

7 Apr 2010

MDA, FFSHR award $200,000 grant for developing FSH dystrophy therapy

The Muscular Dystrophy Association (MDA), headquartered in Tucson, Ariz., and Friends of FSH Research (FFSHR), based in Kirkland, Wash., has jointly awarded a two-year, $200,000 grant to Dr. Joel Chamberlain, a research assistant professor of medical genetics at the University of Washington. The grant, equally funded by the two organizations, will enable the laboratory led by Dr. Chamberlain to study RNA interference as an investigative and therapeutic tool for facioscapulohumeral muscular dystrophy.

7 Apr 2010

Semel Institute for Neuroscience and Human Behavior awarded $14.9M to establish IPCN facility

The Semel Institute for Neuroscience and Human Behavior at UCLA has been awarded $14.9 million in American Recovery and Reinvestment Act funds to establish a center dedicated to interdisciplinary research on the role of genetic and environmental factors in neuropsychiatric and behavioral disorders.

7 Apr 2010

Promising treatment for children with high-functioning autism spectrum disorders

A unique treatment program at Canisius College offers hope to children with high-functioning autism spectrum disorders (Asperger's, high-functioning autism, and PDDNOS), which are characterized by lifelong impairments in social-communicative functioning and narrow and repetitive behaviors and interests.

7 Apr 2010

TD2 to join GPEC at BayBio2010 to spur Arizona's bioscience industry

Scottsdale-based TGen Drug Development will join the Greater Phoenix Economic Council this week at BayBio2010 in an effort to spur Arizona's bioscience industry.

7 Apr 2010

Senator Grassley issues warning about 'phanton pharmacies' while Tampa officials arrest pharmacists on fraud charges

Senator Charles Grassley, R-Iowa, wrote a letter to Department of Health and Human Services Secretary Kathleen Sebelius this week saying federal officials have failed to stop the growing trend of "phantom pharmacies" that bill millions to Medicare in prescription drug costs then disappear, ABC News reports.

7 Apr 2010

Sickle cell disease: Rehospitalization rates high

7 Apr 2010

AHRQ: Women accounted for nearly 60% of 39.4M admissions to U.S. hospitals in 2007

Women accounted for nearly 60 percent of the 39.4 million admissions to U.S. hospitals in 2007, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

7 Apr 2010

ESC heart failure meeting encourages audience interaction

"Delegates attending the meeting will get real insights into what's new in heart failure," said Professor Stefan Anker, chairman of the Heart Failure Congress Scientific Committee. "In what's the biggest international stand-alone meeting dedicated to heart failure, there'll be lots of hot of the press news. The very fact that 12 late breaking clinical trial updates are being presented at the meeting demonstrates how bright the future is in heart failure."

7 Apr 2010

Hospital charges for uninsured inpatient care grows by 88%

The amount that hospitals charge the uninsured for inpatient care grew by 88 percent between 1998 and 2007, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. The average charge for an uninsured hospital stay grew from $11,400 in 1998 to $21,400 in 2007 after adjusting for inflation.

7 Apr 2010

A 2% decline in U.S. birth rate including teenage births

According to Government statistics released this Tuesday, the birthrate in the United States has dropped by 2% from 2007 to 2008 with about 4.2 million babies born during this time. This drop also means that the fertility rate has gone below 2.1 children per woman. This statistic means that Americans are not giving birth to enough children to keep the population from declining.

7 Apr 2010

Doctors prepare to take recertification tests; California case examines patient safety

The Associated Press: "For the first time since leaving medical school, many doctors are having to take tests to renew board certification in their fields — 147 specialties from dermatology to obstetrics. Any doctor can deliver a baby, treat cancer, or declare himself a cardiologist. Certification means the doctor had special training in that field and passed an exam to prove knowledge of it.

7 Apr 2010

Jantibody Therapeutics, Pfenex collaborate in production of HSP-avidin fusion proteins

Boston BioCom LLC today announced the successful completion of a collaborative research agreement between its Jantibody Therapeutics LLC subsidiary and Pfenex Inc., resulting in the rapid production of a HSP-avidin fusion protein for the Jantibodies self-assembling vaccines platform.

7 Apr 2010

Crucell, GSK sign agreement to develop 'second generation malaria vaccine'

Crucell, the Dutch biotechnology company, "said on Tuesday it had agreed with Britain's GlaxoSmithKline to jointly develop a malaria vaccine candidate, without disclosing financial details," Reuters reports (Gray-Block, 4/6).

7 Apr 2010

Media look at regional effect of China's drought

In light of the "first-ever summit of Mekong nations," where participating countries hailed "China's move to share data on reservoir levels," Bloomberg/BusinessWeek examines the "severe drought" affecting more than 60 million people in countries along Asia's Mekong river.

7 Apr 2010

Opexa Therapeutics to present data from Phase 2b TERMS clinical trial for Tovaxin at 62nd AAN meeting

Opexa Therapeutics, Inc., a company developing a novel T-cell therapy for multiple sclerosis (MS), announced today that the Company has been selected to present key efficacy data at the upcoming American Academy of Neurology (AAN) 62nd Annual Meeting to be held in Toronto, Canada.

7 Apr 2010

Eating protein-rich eggs for breakfast reduces hunger, decreases calorie consumption throughout the day

A new study demonstrates that eating protein-rich eggs for breakfast reduces hunger and decreases calorie consumption at lunch and throughout the day. The study, published in the February issue of Nutrition Research, found that men who consumed an egg-based breakfast ate significantly fewer calories when offered an unlimited lunch buffet compared to when they ate a carbohydrate-rich bagel breakfast of equal calories.

7 Apr 2010

Research News and Research

Researchers commence Phase 2 research study to test CERE-110 for AD

Study provides benchmark data to evaluate quality of management of sickle cell disease

Tigermed Consulting signs alliance agreement with ICON

Research highlights first steps in the formation of Lewy bodies, the hallmark of Parkinson's brain

MDA, FFSHR award $200,000 grant for developing FSH dystrophy therapy

Semel Institute for Neuroscience and Human Behavior awarded $14.9M to establish IPCN facility

Promising treatment for children with high-functioning autism spectrum disorders

TD2 to join GPEC at BayBio2010 to spur Arizona's bioscience industry

Senator Grassley issues warning about 'phanton pharmacies' while Tampa officials arrest pharmacists on fraud charges

Sickle cell disease: Rehospitalization rates high

AHRQ: Women accounted for nearly 60% of 39.4M admissions to U.S. hospitals in 2007

ESC heart failure meeting encourages audience interaction

Hospital charges for uninsured inpatient care grows by 88%

A 2% decline in U.S. birth rate including teenage births

Doctors prepare to take recertification tests; California case examines patient safety

Jantibody Therapeutics, Pfenex collaborate in production of HSP-avidin fusion proteins

Crucell, GSK sign agreement to develop 'second generation malaria vaccine'

Media look at regional effect of China's drought

Opexa Therapeutics to present data from Phase 2b TERMS clinical trial for Tovaxin at 62nd AAN meeting

Eating protein-rich eggs for breakfast reduces hunger, decreases calorie consumption throughout the day

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence